Avalo Therapeutics
AVTX
AVTX
37 hedge funds and large institutions have $148M invested in Avalo Therapeutics in 2019 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
Holders
37
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$341K | |
| 2 | +$265K | |
| 3 | +$217K | |
| 4 |
Morgan Stanley
New York
|
+$128K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$78.6K |
Top Sellers
| 1 | -$305K | |
| 2 | -$218K | |
| 3 | -$136K | |
| 4 |
WG
Winton Group
London,
United Kingdom
|
-$90K |
| 5 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$35K |